OUR SERVICES
OUR SCIENCES
Biomolecular condensates form membrane-free intracellular assemblies by liquid-liquid phase separation (LLPS). These droplets are dynamic, reversible compartments. We provide professional biophysical, biochemical, and biogenesis services for biomolecular condensates to get your advanced therapies to market faster.
Centered on physics, we apply droplet microfluidics, statistical thermodynamics, and soft condensed matter physics methods to characterize condensates with precision, allowing us to depict condensates in molecular detail.
LLPS occurs in living cells and is the basis for membrane-free compartment formation and function. We are systematically measuring intracellular LLPS,and using LLPS to discover small molecules that can modulate the protein interactions found in disease states.
We are expanding insights through machine learning, and extensive datasets are used in algorithms for target discovery, target validation, and drug design to accelerate preclinical translation.
WHAT WE DO
CD BioSciences brings success to our clients through a proprietary workflow that combines fundamental knowledge of biomolecular condensates with years of experience. We are committed to delivering services on time, while maintaining superior quality. We are always striving to exceed our clients' expectations.
Our team of experts will design customized solutions based on client needs. Clients can submit a request for proposal on how to solve the problem under cost constraints and schedule.
We will meet your goals as much as possible based on the project implementation plan. You can be involved in participating in the experimental process to discuss with us. We have strict quality control for each experimental step.
We will record the experimental data completely and comprehensively and provide you with the results. If you have any questions, our experts will answer them in detail.
Are you interested in learning more about condensates tools to accelerate your research?
CD BioSciences is a company conducting biomolecular condensates targeted innovative drugs. We integrate the latest advances in physics, chemistry, biology, and machine learning to address some of the most fundamental challenges in health and disease today.